Phase II Trial of S-1 plus Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27-9902 Step2)-Reference-Cited by-同舟云学术

Phase II Trial of S-1 plus Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27-9902 Step2)

Published:2010 Issue:5-6 Volume:79 Page:337-342
ISSN:1423-0232
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Nakata Bunzo,Tsuji Akihito,Mitachi Yasushi,Taenaka Naoyuki,Kamano Toshiki,Oikawa Keisuke,Onoda Naoyoshi,Kambe Mariko,Takahashi Masahiro,Shirasaka Tetsuhiko,Morita Satoshi,Sakamoto Junichi,Tanaka Yukari,Saji Shigetoyo,Hirakawa Kosei

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference23 articles.

1. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.

2. Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo

3. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

4. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

5. Reply to D. Vordermark

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive factors for ocular complications caused by anticancer drug S-1;Japanese Journal of Ophthalmology;2016-02-03

2. Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients;World Journal of Surgical Oncology;2014

3. A randomized phase II study comparing S-1 plus weekly split-dose cisplatin with S-1 plus standard-dose cisplatin as first-line chemotherapy for advanced gastric cancer;Gastric Cancer;2013-07-13

4. Review of clinical investigation on recurrence of gastric cancer following curative resection;CHINESE MED J-PEKING;2012

5. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer;European Journal of Surgical Oncology (EJSO);2012-02